NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/04/2020
Back to search
Official data from USPTO
OMRIX BIOPHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
05/04/2020
Trademark type
Combined
Nice classes
5
Filing date
09/05/2007
Registration date
08/24/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/04/2020
Last transaction
05/04/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2007-06-00
First use in commerce
2007-06-00
Drawing code
5
Owner type
03
Owner location
Somerville, NJ, US
Examiner
LAMOTHE, LESLEY
Law office
L70
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the words "OMRIX BIOPHARMACEUTICALS" in stylized letters.
Holders and representatives
Holders
Omrix Biopharmaceuticals, Inc.
Representatives
Marci A. Blazer Johnson & Johnson
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for biosurgerypharmaceuticals for halting bleeding; antiadhesivespharmaceutical preparations for preventing tissue adhesion following surgery; pharmaceutical preparations for sealingfibrin sealants and fibrin glues for surgery
Publications
History of USPTO decisions and trademark events.
52 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/04/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/04/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/30/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
02/27/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/24/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/29/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/29/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/29/2016
E815
TEAS SECTION 8 & 15 RECEIVED
01/28/2016
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/27/2016
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/27/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/07/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/07/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
08/24/2010
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/23/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
07/22/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/22/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/13/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/13/2010
IUAF
USE AMENDMENT FILED
06/18/2010
EISU
TEAS STATEMENT OF USE RECEIVED
06/18/2010
EX1G
SOU EXTENSION 1 GRANTED
01/05/2010
EXT1
SOU EXTENSION 1 FILED
01/05/2010
EEXT
SOU TEAS EXTENSION RECEIVED
01/05/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
07/07/2009
PUBO
PUBLISHED FOR OPPOSITION
04/14/2009
NPUB
NOTICE OF PUBLICATION
03/25/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/07/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
02/27/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/27/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
02/27/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/27/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/15/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/15/2009
ALIE
ASSIGNED TO LIE
01/15/2009
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/13/2009
EXPI
EX PARTE APPEAL-INSTITUTED
01/13/2009
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
01/13/2009
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
01/13/2009
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/15/2008
GNFR
FINAL REFUSAL E-MAILED
07/15/2008
CNFR
FINAL REFUSAL WRITTEN
07/15/2008
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/16/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/16/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/16/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/16/2008
CNRT
NON-FINAL ACTION MAILED
12/14/2007
CNRT
NON-FINAL ACTION WRITTEN
12/13/2007
DOCK
ASSIGNED TO EXAMINER
12/11/2007
NWAP
NEW APPLICATION ENTERED
09/10/2007
Continuous trademark protection
Get notified about every new filing that threatens OMRIX BIOPHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.